35 completed, 7 unknown, 6 recruiting, 4 not yet recruiting. 22 Phase 1, 19 Phase 3, 6 Phase 4, 4 Phase 2, 1 Not applicable.
Follow Daewon Pharmaceutical Co., Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Multiple Ascending Dose Study of DW4421 DW4421S-T0, DW4421S-T2, DW4421S-T1 - Healthy Adult Volunteers | Phase 1 | Not yet recruiting | Daewon Pharmaceutical Co., Ltd. | 56 | 2026-09-01 | 2026-07-08 |
| A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetics of DW4421-T1 and DW4421S-T1 in Healthy Adult Volunteers DW4421-T1, DW4421S-T1 - Healthy Adult Volunteer | Phase 1 | Not yet recruiting | Daewon Pharmaceutical Co., Ltd. | 38 | 2026-03-06 | 2026-01-23 |
| Evaluate the Safety, Tolerability and Pharmacokinetics of DW5524 in Healthy Adult Volunteers DW5524, DW5524-A - Healthy Adult | Phase 1 | Not yet recruiting | Daewon Pharmaceutical Co., Ltd. | 48 | 2026-02-01 | 2026-01-20 |
| Drug-Drug Interaction Between DW4421 and Amoxicillin/Clarithromycin DW4421, DW4421-1, DW4421-2 - Healthy Adult Volunteers | Phase 1 | Not yet recruiting | Daewon Pharmaceutical Co., Ltd. | 36 | 2026-02-01 | 2026-02-04 |
| A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetics of DW4421 and DW4421S in Healthy Adult Volunteers DW4421, DW4421S - Healthy Adult Volunteer | Phase 1 | Enrolling by invitation | Daewon Pharmaceutical Co., Ltd. | 38 | 2025-12-28 | 2026-01-23 |
| A Phase 1 Clinical Trial to Evaluate the Safety and DDI of DW4421 and 3 NSAIDs DW4421, DW4421-N1, DW4421-N2 - Healthy Adult | Phase 1 | Recruiting | Daewon Pharmaceutical Co., Ltd. | 150 | 2025-12-01 | 2026-01-15 |
| Comparison of DW-1021 and Separate Doses of Pelubi CR and Zytram CR Under Fasting Conditions DW-1021, Pelubi CR + Zytram CR - Healthy Volunteer | Phase 1 | Recruiting | Haiphong University of Medicine and Pharmacy | 14 | 2025-09-20 | 2025-08-28 |
| Food Effect on PK of DW-1021 (Pelubiprofen 45 mg / Tramadol 45.9 mg) in Healthy Adults DW-1021 - Healthy Volunteers, Pharmacokinetics | Phase 1 | Recruiting | Haiphong University of Medicine and Pharmacy | 14 | 2025-09-20 | 2025-08-28 |
| Clinical Trial to Evaluate the Safety, Pharmacokinetic Characteristics of DW5124 and DW5124-R, and the Effect of Food on DW5124 in Healthy Adult Volunteers DW5124, DW5124-R - Mixed Dyslipidemia | Phase 1 | Completed | Daewon Pharmaceutical Co., Ltd. | 55 | 2025-05-08 | 2026-01-06 |
| Comparison of Pitavastatin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus Combination therapy, High intensity statin monotherapy - ASCVD, Diabetes | Phase 4 | Recruiting | Korea University Anam Hospital | 2000 | 2025-04-25 | 2025-04-27 |
| Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of DW5421A/DW5421B Compared to Monotherapy of DW5421A DW5421A, DW5421B Placebo, DW5421B - Primary Hypercholesterolemia, Mixed Dyslipidemia | Phase 3 | Completed | Daewon Pharmaceutical Co., Ltd. | 184 | 2025-04-21 | 2026-03-06 |
| Study to Evaluate the Effect of Food on the Pharmacokinetics and Pharmacodynamics Characteristics in Healthy Adult Volunteers DW4421 - GERD (Gastroesophageal Reflux Disease) | Phase 1 | Completed | Daewon Pharmaceutical Co., Ltd. | 24 | 2024-11-21 | 2026-01-23 |
| Study to Evaluate the Efficacy and Safety of DW1807 in Perennial Allergic Rhinitis Patients With Asthma Experimental, Comparator - Perennial Allergic Rhinitis Accompanied by Asthma | Phase 3 | Recruiting | Daewon Pharmaceutical Co., Ltd. | 274 | 2024-09-09 | 2025-09-11 |
| A Study to Evaluate the Efficacy and Safety of DW5121 Compared to DW51211 and DW51212 DW5121, DW51211, DW51212 - Acute Bronchitis | Phase 3 | Completed | Daewon Pharmaceutical Co., Ltd. | 273 | 2024-03-28 | 2025-07-30 |
| Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia Choline fenofibrate, Policosanol - Dyslipidemia, Atherosclerosis | Phase 4 | Recruiting | Seoul National University Bundang Hospital | 56 | 2023-06-01 | 2026-05-05 |
| Clinical Trial to Evaluate the Efficacy and Safety of DW1026C1 or DW1026C2 DW1026C1, DW1026C2, DW1026S - Type 2 Diabetes | Phase 3 | Completed | Daewon Pharmaceutical Co., Ltd. | 230 | 2022-10-27 | 2025-07-21 |
| Clinical Trial to Evaluate the Efficacy and Safety of DW1125 and DW1125A Ezetimibe/Atorvastatin 10/5 mg, Atorvastatin 5mg, Ezetimibe 10mg - Hypercholesterolemia, Dyslipidemia | Phase 3 | Completed | Daewon Pharmaceutical Co., Ltd. | 252 | 2022-08-17 | 2023-08-01 |
| Clinical Trial to Evaluate the Pharmacokinetic Characteristics of DW5221 and DW5221-R DW5221, DW5221-R - Apetite Stimulants | Phase 1 | Completed | Daewon Pharmaceutical Co., Ltd. | 54 | 2022-07-01 | 2023-11-28 |
| Clinical Trial to Evaluate the Efficacy and Safety of DWKH DWKH, DWKH-R, Placebo - Respiratory Infection | Phase 3 | Completed | Daewon Pharmaceutical Co., Ltd. | 186 | 2021-11-26 | 2023-01-13 |
| Clinical Trial to Evaluate the Efficacy and Safety of DW4902 DW4902 Placebo, DW4902 160mg, DW4902 240mg - Myoma of Uterus | Phase 2 | Completed | Daewon Pharmaceutical Co., Ltd. | 71 | 2021-10-06 | 2026-01-07 |
Showing 20 of 53. Sign in to see all of them.
Dyslipidemias (5) · Arthritis, Rheumatoid (3) · Hypercholesterolemia (3) · Back Pain (2) · Bronchitis (2) · Diabetes Mellitus, Type 2 (2) · Hypertension (2) · Kidney Failure, Chronic (2) · Osteoarthritis (2) · Respiratory Tract Infections (2) · Atherosclerosis (1) · Diabetes Mellitus (1) · Fever (1) · Gastritis (1) · Gastroesophageal Reflux (1)
pelubiprofen (8) · Tramadol (4) · Acetaminophen (3) · Rosuvastatin Calcium (3) · Amlodipine (2) · Telmisartan (2) · Aging (1) · Atorvastatin (1) · BID protein, human (1) · Celecoxib (1) · Combined Modality Therapy (1) · Ezetimibe (1) · Fenofibrate (1) · Megestrol (1) · Megestrol Acetate (1)
South Korea (35) · Vietnam (2) · Israel (1)
Bumseok Kim, Professor (1) · Hyeong-Cheon Park, Professor (1) · Jaejeong Shim, Principal Investigator (1) · Sunghoon Kim (1) · Yossi Azuri, MD (1)
PMID 25403311, PMID 41821212, PMID 10333939, PMID 11270938, PMID 12087009, PMID 12186811, PMID 17559928, PMID 17601626, PMID 20167359, PMID 21693744, PMID 21809372, PMID 22410123, PMID 23704171, PMID 24239923, PMID 28886621, PMID 29165385, PMID 29263150, PMID 29718253, PMID 30559228, PMID 30586774, PMID 30586775, PMID 31466435, PMID 31504418, PMID 31518657, PMID 33272643, PMID 33381933, PMID 3358991, PMID 34518033, PMID 35800670, PMID 37309193, PMID 38586120, PMID 40094866, PMID 41883295